Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Observational × Doxorubicin × Clear all

Status

Sponsor Class

OTHER 18 NETWORK 1

Study Type

Interventional 145 Observational 1

Sponsor

Cancer Type

Conditions

Interventions

Gene Expression Profiling 64 Polymerase Chain Reaction 37 Microarray Analysis 37 Amplified Fragment Length Polymorphism Analysis 32 Immunohistochemistry 28 Flow Cytometry 25 Reverse Transcriptase Polymerase Chain Reaction 20 DNA Methylation 14 Blotting, Western 13 Cytogenetic Analysis 11 Base Sequence 10 Psychiatric Rehabilitation 8 In Situ Hybridization, Fluorescence 8 Immunologic Techniques 8 Pharmacogenomic Testing 5 Mental Status and Dementia Tests 5 Mass Spectrometry 5 Gene Rearrangement 5 Enzyme-Linked Immunosorbent Assay 5 Comparative Genomic Hybridization 5 Watchful Waiting 4 Surveys and Questionnaires 4 Immunoenzyme Techniques 4 Chromosome Mapping 4 Therapeutics 3 Paclitaxel 3 Cisplatin 3 Carboplatin 3 Vincristine 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02986503 2016-12-08

EUROBOSS

Italian Sarcoma Group

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡